Lobular Breast Carcinoma Clinical Trial
Official title:
Initial Staging of Lobular Breast Carcinoma: Head to Head Comparison of 68Ga-FAPI-46 and 18F-FDG PET/CT
Lobular Breast cancer staging with 18F-fluorodeoxyglucose positron emission tomography (18F-FDG PET) is not optimal due to the poor accumulation of 18F-FDG in the tumour. Through better sensitivity (and specificity), 68Ga-FAPI-46-46 PET should provide a more accurate staging of lobular breast cancer than 18F-FDG PET.
Research hypothesis : Through better sensitivity (and specificity), 68Ga-FAPI-46-46 PET should provide a more accurate staging of lobular breast cancer than 18F-FDG PET. Participants with lobular breast carcinoma will then undergo 18F-FDG and 68Ga-FAPI-46 PET scan. Primary objective of the study is to compare the sensitivity of 68Ga-FAPI-46 with the sensitivity of 18F-FDG in the detection of lobular breast carcinoma lesions, measured by positron emission tomography (PET). These results will be compared with the histological data collected before or during surgery (conventional histological data and immunohistochemical labeling of FAPĪ± on the sample obtained), clinical follow-up and any results of additional examinations carried out within the usual clinical follow-up of the patients. Comparison of primary tumor and metastases uptake of 68Ga-FAPI-46 with the uptake of 18F-FDG, radiomic study of 68Ga-FAPI-46 PET and comparative radiomic study of 68Ga-FAPI-46 PET and 18F-FDG PET and comparison of the specificity of 68Ga-FAPI-46 with the specificity of 18F-FDG after a 12-month follow-up will also be performed as secondary objectives. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT05982496 -
18F FES-PET/MRI for Tailoring Treatment of Luminal A and Lobular Breast Cancer
|
N/A | |
Active, not recruiting |
NCT03620643 -
Crizotinib in Lobular Breast, Diffuse Gastric and Triple Negative Lobular Breast Cancer or CDH1-mutated Solid Tumours
|
Phase 2 | |
Completed |
NCT01753908 -
Broccoli Sprout Extract in Treating Patients With Breast Cancer
|
Early Phase 1 | |
Recruiting |
NCT05410951 -
LobularCard Trial: Searching for Novel Germline Mutations in Lobular Breast Cancer Patients
|
||
Active, not recruiting |
NCT03414970 -
Hypofractionated Radiation Therapy After Mastectomy in Preventing Recurrence in Patients With Stage IIa-IIIa Breast Cancer
|
Phase 3 | |
Recruiting |
NCT05837767 -
A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue
|
N/A | |
Active, not recruiting |
NCT01038258 -
Monitoring Response After The First Chemotherapy Cycle After Neoadjuvant Breast Cancer Therapy
|
N/A | |
Completed |
NCT03834532 -
Living Well After Breast Surgery
|
N/A | |
Recruiting |
NCT05964504 -
Improving Survival for Metastatic Lobular Breast Cancer (PLUMB Registry)
|
||
Active, not recruiting |
NCT04206891 -
CDH1 Germline Mutations in Lobular Breast Cancer
|
||
Recruiting |
NCT06067503 -
Biomarkers to Detect Endocrine Therapy Resistance
|
Phase 2 |